Sosei Group

About:

Sosei is a Japanese biopharmaceutical company that develops and commercializes innovative drugs.

Website: http://sosei.com/en/

Top Investors: JAFCO, Resona Capital, Scottish Equity Partners, Mitsui Global Investment, Nomura Holdings

Description:

Sosei Group Corporation is an international biopharmaceutical company originating from Japan that discovers and develops innovative biopharmaceuticals for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications. By utilizing their platform technologies - GPCR structure-based drug design platform technology, peptide platform technologies and nanotechnology - they have established a product pipeline with first/best in class potential. Through development and commercialization partnerships they have already delivered three medicines to the market (two COPD bronchodilators and an emergency contraceptive), which generate significant and stable revenue streams that enable further growth.